Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 27
1964 74
1965 39
1966 52
1967 63
1968 81
1969 128
1970 149
1971 123
1972 153
1973 163
1974 176
1975 132
1976 137
1977 126
1978 160
1979 162
1980 144
1981 148
1982 162
1983 193
1984 198
1985 242
1986 209
1987 241
1988 309
1989 298
1990 299
1991 291
1992 288
1993 359
1994 322
1995 373
1996 347
1997 379
1998 363
1999 383
2000 433
2001 444
2002 477
2003 553
2004 493
2005 596
2006 751
2007 844
2008 791
2009 867
2010 958
2011 975
2012 1099
2013 1116
2014 1089
2015 1201
2016 1261
2017 1294
2018 1362
2019 1410
2020 1317
2021 1126
2022 948
2023 1123
2024 920
2025 742

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,357 results

Results by year

Filters applied: Clinical Trial, Meta-Analysis, Randomized Controlled Trial, Review, Systematic Review, in the last 5 years. Clear all
Page 1
Guidelines From the French-Speaking Society for Histocompatibility and Immunogenetics (SFHI) for Harmonisation of HLA Genotyping in Autoimmune Diseases, Drug Hypersensitivity and Pharmacogenetics.
Renac V, Moalic V, Dautin G, Cherel M, Mercier B, Walencik A, Cohen J, Farce F, Proust B, Kaveri R, Humeau C, Picard C, Pedron B, Dubois V, Taupin JL, Elsermans V, Top-Raymond I, Ferrari-Lacraz S, Barocas A, Masson D, Essaydi A, Guidicelli G, Ralazamahaleo M, Congy-Jolivet N. Renac V, et al. HLA. 2025 Oct;106(4):e70442. doi: 10.1111/tan.70442. HLA. 2025. PMID: 41137743 Review.
Methods for implementing and reporting the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events to measure patient-reported adverse events in cancer clinical trials.
Dueck AC, Thanarajasingam G, Rogak L, Mazza GL, Langlais BT, Noble BN, Ginos BF, Mead-Harvey C, Yee CI, Lee MK, Deal AM, Meek EA, Basch E. Dueck AC, et al. Cancer. 2025 Oct 15;131 Suppl 2(Suppl 2):e35951. doi: 10.1002/cncr.35951. Cancer. 2025. PMID: 41123546 Free PMC article. Review.
Measuring the multidimensional aspects of tolerability.
Mitchell SA, Altshuler RD, St Germain DC, Streck BP, Chen AP, Minasian LM. Mitchell SA, et al. Cancer. 2025 Oct 15;131 Suppl 2(Suppl 2):e70085. doi: 10.1002/cncr.70085. Cancer. 2025. PMID: 41123478 Free PMC article. Review.
[Drug Excipients. Necessary, but not Harmless].
López Alarcón MD, Justo Hernández A, Santos Cruz P. López Alarcón MD, et al. Farm Comunitarios. 2025 Oct 1;17(4):65-80. doi: 10.33620/FC.2173-9218.(2025).30. eCollection 2025 Oct 15. Farm Comunitarios. 2025. PMID: 41122218 Free PMC article. Review. Spanish.
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus.
van Vollenhoven RF, Wang L, Merrill JT, Liu Y, Bao C, Li F, Hu J, Huang C, Zhao J, Huang C, Mo H, Wei W, Lu F, Li J, Zhao D, Wang W, Li L, Zuraw Q, Wang X, Wang X, Fang J, Zhang F; 18C010 Trial Investigators. van Vollenhoven RF, et al. N Engl J Med. 2025 Oct 16;393(15):1475-1485. doi: 10.1056/NEJMoa2414719. N Engl J Med. 2025. PMID: 41092329 Clinical Trial.
[Cutaneous reactions to drugs].
Lederbogen I, Meier-Schiesser B. Lederbogen I, et al. Ther Umsch. 2025 Sep;82(4):111-116. doi: 10.23785/TU.2025.04.003. Ther Umsch. 2025. PMID: 41031693 Review. German.
Association of HLA-B*53 With DRESS Syndrome in Patients Treated With Raltegravir: Two Case Reports and a Literature Review.
Ramos-Del Moral C, Rodríguez Cortés P, Navares-Gómez M, Campodónico D, Almenara de Riquer S, Barrios Blandino A, Mejía-Abril G, Gómez-Fernández A, Romero Sastre O, Carles García P, Abad-Santos F. Ramos-Del Moral C, et al. Basic Clin Pharmacol Toxicol. 2025 Nov;137(5):e70118. doi: 10.1111/bcpt.70118. Basic Clin Pharmacol Toxicol. 2025. PMID: 41025677 Free PMC article. Review.
Drug-Induced Periocular and Ocular Surface Disorders: An EAACI Position Paper.
Leonardi A, Bozkurt B, Silva D, Mortz CG, Baudouin C, Atanaskovic-Markovic M, Sharma V, Doan S, Agarwal S, Pérez-Formigo D, Vasconcelos MJ, Baudouin FB, Chorzepa G, Fauquert JL, Calder V, Demoly P, Delgado L. Leonardi A, et al. Allergy. 2025 Nov;80(11):2953-2972. doi: 10.1111/all.70074. Epub 2025 Sep 30. Allergy. 2025. PMID: 41025570 Free PMC article. Review.
Adverse Effects and Drug Reactions in Equids.
Wilson KE, Davis JL. Wilson KE, et al. Vet Clin North Am Equine Pract. 2025 Dec;41(3):653-674. doi: 10.1016/j.cveq.2025.08.011. Epub 2025 Sep 24. Vet Clin North Am Equine Pract. 2025. PMID: 40998644 Review.
Adverse drug reaction reporting with the Med Safety app in Uganda: a cluster-randomised, controlled trial.
Kiguba R, Ndagije HB, Mwebaza N, Ssenyonga R, Giibwa L, Isabirye G, Owiny J, Nambasa V, Ntale I, Atuhaire J, Mwesigwa D, Mayengo J, Walusimbi D, Mugisa I, Katureebe C, Harrison K, Karamagi C, Pirmohamed M. Kiguba R, et al. Lancet Glob Health. 2025 Oct;13(10):e1761-e1770. doi: 10.1016/S2214-109X(25)00299-2. Lancet Glob Health. 2025. PMID: 40975083 Free PMC article. Clinical Trial.
Diagnosis of Quinolone Hypersensitivity: An EAACI Position Paper.
Gelincik A, Brockow K, Çelik GE, Demir S, Doña Diaz I, Ebo DG, Mayorga C, Labella M, Sabato V, Jaén MJT. Gelincik A, et al. Allergy. 2025 Nov;80(11):2988-3011. doi: 10.1111/all.70037. Epub 2025 Sep 10. Allergy. 2025. PMID: 40931617 Review.
[Frailty and pharmacotherapy].
Eidam A, Seidling HM, Stingl JC, Bauer JM. Eidam A, et al. Inn Med (Heidelb). 2025 Oct;66(10):1025-1031. doi: 10.1007/s00108-025-01980-8. Epub 2025 Sep 3. Inn Med (Heidelb). 2025. PMID: 40900156 Review. German.
Epidermal growth factor receptor inhibitor-related skin toxicities: a review of management and possible preventive and therapeutic approaches for Asian patients by the Japanese Pharmacist-led Oncodermatology Study Team.
Iimura Y, Iihara H, Saito Y, Nomura H, Iwamoto T, Kotera M, Tsuchiya Y, Sumiya T, Kono M, Hirate D, Kurokawa T, Hayashi T, Hashimoto H, Higuchi J, Urakawa R, Saotome H, Kuroda S. Iimura Y, et al. Int J Clin Oncol. 2025 Nov;30(11):2192-2207. doi: 10.1007/s10147-025-02868-1. Epub 2025 Sep 1. Int J Clin Oncol. 2025. PMID: 40888993 Free PMC article. Review.
Dermatological impacts of urological cancer treatments.
Sataray-Rodriguez A, Oladinni D, Adler R, Doshi N, Patrick B, Aust N, Sun M, Schur N, Jamieson S, P Weiss J. Sataray-Rodriguez A, et al. World J Urol. 2025 Aug 31;43(1):521. doi: 10.1007/s00345-025-05896-8. World J Urol. 2025. PMID: 40887555 Review.
Sacubitril/Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical Trial.
Omland T, Heck SL, Holte E, Lilleaasen AM, Gynnild MN, Fagerland MW, Vinje-Jakobsen V, Næs AL, Blix ES, Larsen AI, Geisler J, Gulati G, Wethal T. Omland T, et al. Circulation. 2025 Oct 21;152(16):1136-1145. doi: 10.1161/CIRCULATIONAHA.125.076616. Epub 2025 Aug 29. Circulation. 2025. PMID: 40884047 Free PMC article. Clinical Trial.
Direct penicillin allergy challenge.
[No authors listed] [No authors listed] Drug Ther Bull. 2025 Oct 27;63(11):163. doi: 10.1136/dtb.2025.000037. Drug Ther Bull. 2025. PMID: 40829860
Quality indicators for safe and effective use of medications in long-term care settings: A systematic review.
Gutteridge DS, Calder AH, Stasinopoulos J, Javanparast S, Caughey GE, Hillen JB, Stafford AC, Peterson GM, Inacio MC, Khadka J, Kalisch Ellett LM, Jackson SL, Hibbert PD, Cations ML, Corlis ME, Yu SC, Clark MJ, Soulsby NR, Manias E, Yoo GH, Sluggett JK. Gutteridge DS, et al. Br J Clin Pharmacol. 2025 Nov;91(11):3054-3069. doi: 10.1002/bcp.70242. Epub 2025 Aug 18. Br J Clin Pharmacol. 2025. PMID: 40825531 Free PMC article. Review.
Unravelling drug-induced hepatic steatosis: Clinical sub-phenotypes, outcome prediction, and identification of high-concern drugs and hazardous chemical attributes.
Moreno-Torres M, López-Pascual E, Moro E, Rapisarda A, Lindeman B, Verhoeven A, Luechtefeld T, Serrano-Candelas E, Dirven H, Vinken M, Castell JV, Jover R. Moreno-Torres M, et al. Biomed Pharmacother. 2025 Oct;191:118459. doi: 10.1016/j.biopha.2025.118459. Epub 2025 Aug 15. Biomed Pharmacother. 2025. PMID: 40818362 Free article. Review.
A phase II study evaluating the preventive effect of topical hydrocortisone for capecitabine-induced hand-foot syndrome in patients with colorectal cancer receiving adjuvant chemotherapy with capecitabine plus oxaliplatin (T-CRACC study).
Iimura Y, Baba K, Furukawa N, Ishibashi M, Sasuga C, Ahiko Y, Monma S, Sakuyama N, Aikou S, Shida D, Nojima M, Kuroda S, Boku N. Iimura Y, et al. Int J Clin Oncol. 2025 Nov;30(11):2316-2324. doi: 10.1007/s10147-025-02857-4. Epub 2025 Aug 14. Int J Clin Oncol. 2025. PMID: 40810825 Free PMC article. Clinical Trial.
Mast cell conditions and drug allergy.
Olivieri B, Bonadonna P. Olivieri B, et al. Ann Allergy Asthma Immunol. 2025 Nov;135(5):521-529. doi: 10.1016/j.anai.2025.07.030. Epub 2025 Aug 7. Ann Allergy Asthma Immunol. 2025. PMID: 40783101 Review.
[Vestibulopathies and adult cancers: A literature review].
Maquet C, Crampon C, Tendron A, Giraudet F, Ferrand FR, Horion J, Nebbache R, Crampon F, Deneuve S. Maquet C, et al. Bull Cancer. 2025 Oct;112(10):1183-1192. doi: 10.1016/j.bulcan.2025.03.006. Epub 2025 Aug 5. Bull Cancer. 2025. PMID: 40753050 Free article. Review. French.
Medication Safety in Acute Care Settings.
Vasilevskis EE, Chui MA, Mai S, Kripalani S. Vasilevskis EE, et al. Med Clin North Am. 2025 Sep;109(5):1029-1045. doi: 10.1016/j.mcna.2025.02.010. Epub 2025 Apr 7. Med Clin North Am. 2025. PMID: 40752928 Review.
Drug-Induced Retinal Toxicity.
Vyas C, Jolia A, Tsang SH, Sharma T, Diaconita V. Vyas C, et al. Adv Exp Med Biol. 2025;1467:253-262. doi: 10.1007/978-3-031-72230-1_50. Adv Exp Med Biol. 2025. PMID: 40736852 Review.
Efficacy of Aspirin Therapy After Desensitization on Chronic Rhinosinusitis With Nasal Polyps Patients With Asthma and Non-steroidal Anti-inflammatory Drug Exacerbated Respiratory Disease -A Randomized Clinical Trial.
Helevä A, Lyly A, Salmi V, Mäkelä M, Kauppi P, Laulajainen-Hongisto A, Hafrén L, Virkkula P, Nuutinen M, Toppila-Salmi S. Helevä A, et al. Allergy. 2025 Nov;80(11):3151-3164. doi: 10.1111/all.16679. Epub 2025 Jul 29. Allergy. 2025. PMID: 40726272 Free PMC article. Clinical Trial.
Translational aspects of doxorubicin-induced cardiotoxicity: What we have omitted for the past decades?
Avagimyan A, Madonna R, Sheibani M, Pogosova N, Trofimenko A, Urazova O, Iop L, Jndoyan Z, Yeranosyan H, Aznauryan A, Sahakyan K, Petrosyan A, Petrosyan R, Tatoyan M, Mkrtchyan G, Sulemaniayants E, Meltonyan G, Kuzniatsou A, Mukherjee R, Rezabakhsh A, Koliakos G, Ottaviani G, Zoccai GB, Sarrafzadegan N. Avagimyan A, et al. Vascul Pharmacol. 2025 Sep;160:107526. doi: 10.1016/j.vph.2025.107526. Epub 2025 Jul 24. Vascul Pharmacol. 2025. PMID: 40714257 Review.
[Pharmaceutical interventions in the new medicine service].
Borja Ripoll S, Mocholí Belenguer F, Traver Salcedo V. Borja Ripoll S, et al. Farm Comunitarios. 2025 Jun 18;17(3):17-25. doi: 10.33620/FC.2173-9218.(2025).19. eCollection 2025 Jul 15. Farm Comunitarios. 2025. PMID: 40703483 Free PMC article. Review. Spanish.
Age-dependent differences in anaphylaxis: elderly population.
Barone A, Nicoletta F, Ottoni M, Ridolo E. Barone A, et al. Curr Opin Allergy Clin Immunol. 2025 Oct 1;25(5):343-348. doi: 10.1097/ACI.0000000000001091. Epub 2025 Aug 11. Curr Opin Allergy Clin Immunol. 2025. PMID: 40699586 Free PMC article. Review.
The Pragmatic Removal of Penicillin Allergy Electronic Health Record Labels (PROPEL) Trial: A Randomized Clinical Trial.
Stone CA Jr, Prigmore HL, McCoy AB, Stollings JL, Dear ML, Hiser W, Van Winkle G, Kripalani S, Wright A, Harrell FE, Rice TW, Lindsell CJ, Phillips EJ; Vanderbilt Learning Healthcare System Platform Investigators. Stone CA Jr, et al. J Allergy Clin Immunol Pract. 2025 Oct;13(10):2747-2755. doi: 10.1016/j.jaip.2025.07.006. Epub 2025 Jul 16. J Allergy Clin Immunol Pract. 2025. PMID: 40675326 Free article. Clinical Trial.
The Effects on the Growth of HIV-exposed Uninfected Infants of Initiating Dolutegravir-based Versus Efavirenz-based cART in Late Pregnancy (DolPHIN-2).
Hagens L, Bevers LAH, Malaba TR, Nassiwa SC, Mrubata M, Theunissen H, Reynolds H, He N, Read J, Burger DM, Lamorde M, Myer L, Wang D, Khoo S, Waitt C, Colbers A. Hagens L, et al. Pediatr Infect Dis J. 2025 Nov 1;44(11):1066-1071. doi: 10.1097/INF.0000000000004902. Epub 2025 Jul 18. Pediatr Infect Dis J. 2025. PMID: 40674650 Free PMC article. Clinical Trial.
Epidemiology of Antiretroviral Therapy Related Adverse Drug Reactions and its Predictors Among Patients with Human Immunodeficiency Virus/AIDS in Ethiopia: A Systematic Review and Meta-analysis.
Zewdu WS, Dagnew SB, Zeleke MM, Ferede YA, Kassie AB, Moges TA, Alemu MA. Zewdu WS, et al. J Int Assoc Provid AIDS Care. 2025 Jan-Dec;24:23259582251358929. doi: 10.1177/23259582251358929. Epub 2025 Jul 15. J Int Assoc Provid AIDS Care. 2025. PMID: 40665675 Free PMC article.
Positive social modeling attenuates nocebo side effects.
Saunders C, Tan W, Ng D, Burchett A, McNair N, Colagiuri B. Saunders C, et al. Ann Behav Med. 2025 Jan 4;59(1):kaaf048. doi: 10.1093/abm/kaaf048. Ann Behav Med. 2025. PMID: 40662257 Free PMC article. Clinical Trial.
One-bag protocol for cancer drug hypersensitivity: A meta-analysis of safety and effectiveness.
Noyola-Pérez A, González-Díaz SN, Macouzet-Sánchez C, Alanís-Alvarez JM, Muñoz-Silva V, Guzmán-Avilán RI, Macias-Weinmann A, De Lira-Quezada CE, Acuña-Ortega N, Morais-Almeida M, Ansotegui IJ. Noyola-Pérez A, et al. Ann Allergy Asthma Immunol. 2025 Nov;135(5):578-587.e6. doi: 10.1016/j.anai.2025.06.034. Epub 2025 Jul 5. Ann Allergy Asthma Immunol. 2025. PMID: 40623523 Free article.
Drugs and Healthy Aging.
Hilmer SN, Ferrucci L, Cherubini A. Hilmer SN, et al. Drugs Aging. 2025 Jul;42(7):591-598. doi: 10.1007/s40266-025-01208-2. Epub 2025 Jul 3. Drugs Aging. 2025. PMID: 40608209 Free PMC article. Review.
4,357 results